Negative Pressure Wound Therapy to Treat Hematomas and Surgical Incisions Following High-Energy Trauma

2006 ◽  
Vol 60 (6) ◽  
pp. 1301-1306 ◽  
Author(s):  
James P. Stannard ◽  
James T. Robinson ◽  
E Ratcliffe Anderson ◽  
Gerald McGwin ◽  
David A. Volgas ◽  
...  
Injury ◽  
2017 ◽  
Vol 48 (7) ◽  
pp. 1518-1521 ◽  
Author(s):  
Brett D. Crist ◽  
Lasun O. Oladeji ◽  
Michael Khazzam ◽  
Gregory J. Della Rocca ◽  
Yvonne M. Murtha ◽  
...  

2021 ◽  
Vol 10 (2) ◽  
pp. 149-155
Author(s):  
Stefanie M. Shiels ◽  
Nicole M. Sgromolo ◽  
Joseph C. Wenke

Aims High-energy injuries can result in multiple complications, the most prevalent being infection. Vancomycin powder has been used with increasing frequency in orthopaedic trauma given its success in reducing infection following spine surgery. Additionally, large, traumatic injuries require wound coverage and management by dressings such as negative pressure wound therapy (NPWT). NPWT has been shown to decrease the ability of antibiotic cement beads to reduce infection, but its effect on antibiotic powder is not known. The goal of this study was to determine if NPWT reduces the efficacy of topically applied antibiotic powder. Methods Complex musculoskeletal wounds were created in goats and inoculated with a strain of Staphylococcus aureus modified to emit light. Six hours after contaminating the wounds, imaging, irrigation, and debridement and treatment application were performed. Animals received either vancomycin powder with a wound pouch dressing or vancomycin powder with NPWT. Results There were no differences in eradication of bacteria when vancomycin powder was used in combination with NPWT (4.5% of baseline) compared to vancomycin powder with a wound pouch dressing (1.7% of baseline) (p = 0.986), even though approximately 50% of the vancomycin was recovered in the NPWT exudate canister. Conclusion The antimicrobial efficacy of the vancomycin powder was not diminished by the application of NPWT. These topical and locally applied therapies are potentially effective tools that can provide quick, simple treatments to prevent infection while providing coverage. By reducing the occurrence of infection, the recovery is shortened, leading to an overall improvement in quality of life. Cite this article: Bone Joint Res 2021;10(2):149–155.


2021 ◽  
Vol 30 (Sup5) ◽  
pp. S23-S31
Author(s):  
Leo M Nherera ◽  
Chris Saunders ◽  
Sanjay Verma ◽  
Paul Trueman ◽  
Francis Fatoye

Objective: Single-use negative pressure wound therapy (sNPWT) following closed surgical incisions has a demonstrable effect in reducing surgical site complications (SSC). However, there is little health economic evidence to support its widespread use. We sought to evaluate the cost-effectiveness of sNPWT compared with standard care in reducing SSCs following closed surgical incisions. Method: A decision analytic model was developed to explore the total costs and health outcomes associated with the use of the interventions in patients following vascular, colorectal, cardiothoracic, orthopaedic, C-section and breast surgery from the UK National Health Service (NHS) and US payer perspective over a 12-week time horizon. We modelled complications avoided (surgical site infection (SSI) and dehiscence) using data from a recently published meta-analysis. Cost data were sourced from published literature, NHS reference costs and Centers for Medicare and Medicaid Services. We conducted subgroup analysis of patients with diabetes, an American Society of Anesthesiologists (ASA) score ≥3 and body mass index (BMI) ≥30kg/m2. A sensitivity analysis was also conducted. Results: sNPWT resulted in better clinical outcomes and overall savings of £105 per patient from the UK perspective and $637 per patient from the US perspective. There were more savings when higher-risk patients with diabetes, or a BMI ≥30kg/m2 or an ASA≥3 were considered. We conducted both one-way and probabilistic sensitivity analysis, and the results suggested that this conclusion is robust. Conclusion: Our findings suggest that the use of sNPWT following closed surgical incisions saves cost when compared with standard care because of reduced incidence of SSC. Patients at higher risk should be targeted first as they benefit more from sNPWT. This analysis is underpinned by strong and robust clinical evidence from both randomised and observational studies.


2019 ◽  
Vol 24 (7) ◽  
pp. 372-379
Author(s):  
Rachel Nixon

Negative pressure wound therapy, the controlled application of sub-atmospheric pressure to the wound surface, is becoming an increasingly popular treatment modality for the management of wounds in both human and veterinary medicine. It is proposed to exert a number of actions on the wound environment to promote healing. It is well recognised in the management of acute and chronic wounds and with skin grafting. It shows promise in cases of exposed orthopaedic implants and postoperatively on high-risk closed surgical incisions. Close monitoring following application is essential to ensure continued function. Importantly, it is typically well tolerated with minimal associated complications. However, significant complications are reported, if rarely, hence careful decision-making should be implemented to ensure appropriate use.


Sign in / Sign up

Export Citation Format

Share Document